Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Wellness Device Firms Should Follow Regulatory Prompts, Expert Says

This article was originally published in The Gray Sheet

Executive Summary

Many wearable consumer health products entering the market don't fall within the bounds of FDA regulation, but that does not mean companies selling the products should ignore recommendations coming out of the agency, according to Vernessa Pollard, a partner with McDermott, Will & Emery, who spent six years at FDA's Office of Chief Counsel. Maintaining validation according to FDA rules and guidelines makes "good business sense," she said in an interview.


Related Content

ONC Outlines Plan To Expand Telehealth, Mobile Health